Sugar Editorial Picks
May 18, 2008 -
In an upcoming commercial for Nintendo DS, Liv Tyler gets her game on with Brain Age 2, as she attempts one of the training activities — the piano player. Watching her play in game (in her pj's) as she hums the notes, makes this one geekalicious commercial! You can't help but want to get your DS out!
- 11 Comments
Aug 21, 2007 -
Earlier this summer Nicole Kidman had signed on as Nintendo's television ad spokesperson in Europe for More Brain Training from Dr Kawashima: How Old Is Your Brain?, prompting a renewed interest in the series here in the U.S. Of course Brain Age, was already a bona fide hit with Nintendo DS fans around the globe, so everyone has been abuzz about the series' next US feature.
Yesterday, Brain Age 2: More Training in Minutes a Day was released for DS, and let me tell you, it does not disappoint.
- 12 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Causes
- Prognosis
- Diagnosis
- Common Brain Tumors
- Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Other Treatments
- Treatment of Complications...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Radiation Therapy Complications
- Radiation therapy in children with cancer increases the risk of new brain and spinal cord tumors, suggests a study in the Journal of the National Cancer Institute. The risk appears to increase along with the radiation dosage. Children who receive radiotherapy before age 5 are especially at risk for second primary tumors.
- Survivors of childhood brain tumors who received cranial radiotherapy as part of their treatment are at risk for later having a stroke, indicates a study in the Journal of Clinical Oncology.
- 0 Comments
Oct 01, 2009 -
The end of our video-game bracket is drawing to a close, but there's still two more rounds to go! After round two, we've had to say good-bye to favorites like Brain Age and Animal Crossing, but the competition is definitely heating up! In this round of our killer classics video games you'll see games like Call of Duty 2 and World of Warcraft go head-to-head for the ultimate title of best video game ever.
- 4 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Outlook and Effects
- Diagnosis
- Treatment
- Treatment After The First S...
- Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, the Food and Drug Administration (FDA) approved levetiracetam (Keppra) for treatment of primary generalized tonic-clonic seizures in adults, and children ages 6 years and older, who have idiopathic generalized epilepsy. Levetiracetam was previously approved for partial-onset seizures and myoclonic seizures.
Carbamazepine and Genetic Testing
In 2007, the FDA recommended that patients of Asian ancestry get a genetic test prior to taking carbamazepine (Tegetrol, Equetro, Carbatrol).
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Prognosis
- Prevention
- Diagnosis
- Managing a Stroke
- Medications
- Surgery
- Recovery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Statin Drug Approved for Stroke Prevention
- In 2007, the FDA approved the cholesterol drug atorvastatin (Lipitor) to reduce the risk of stroke in patients with heart disease.
- High-dose atorvastatin may help reduce the risk of recurrent stroke in patients who have had a recent stroke or transient ischemic attack, according to a New England Journal of Medicine study.
Drug Warnings
- In 2006, the FDA strengthened the warning label for the anticoagulant drug warfarin (Coumadin) to emphasize its bleeding risks. However, warfarin is still the gold standard treatment for most patients with atrial fibrillation.
- Evidence suggests that people at risk for stroke should avoid taking non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil) and diclofenac (Cataflam). COX-2 inhibitors should only be used as a last resort for pain relief.
- 0 Comments
Sep 04, 2009 -
The next time you're going on a trip and you need something skill-testing and fun to play while in the car or on a plane, I urge you to check out Professor Layton and the Diabolical Box ($30) for the Nintendo DS (OK, I'll admit, I'm a sucker for playing it right before bed). Being one of those people who loves mini-games and brainteasers (Rhythm Heaven and Brain Age 2 being two of my favorite games), I knew I had to take Professor Layton for a test drive when I found out it has 150 puzzles to solve.
When you first turn on the game, you can't help but think it's designed for a child and wonder if the mini games are actually going to be challenging to solve.
- 8 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Prevention
- Symptoms
- Diagnosis
- Medications
- Stages
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Alzheimer’s Disease Toll Increasing
More than 5 million Americans now have Alzheimer’s disease, and the number could increase to 16 million by mid-century, according to a 2007 report from the Alzheimer’s Association.
New Drug Indication
In 2006, the FDA expanded the use of donepezil (Aricept) to include treatment of people with severe dementia associated with Alzheimer’s disease. Donepezil was previously approved only for people with mild-to-moderate dementia.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Vaccinations
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
West Nile Virus
In 2007, 3,510 cases of West Nile virus were reported to the U.S. Centers for Disease Control. States with the highest number of reported cases included Colorado, California, and North Dakota.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Levadopa (L-dopa)
- Other Medications
- Surgery
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the FDA approved the first skin patch drug for treatment of Parkinson’s disease. Transdermal rotigotine (Neupro) is a dopamine agonist drug that may help improve symptoms of early-stage Parkinson’s disease. The patch is applied daily.
- Rivastigimine (Exelon), an Alzheimer’s disease drug, was approved in 2006 for treatment of mild-to-moderate dementia associated with Parkinson’s disease.
Drug Withdrawal
In 2007, the FDA withdrew the dopamine agonist pergolide (Permax) from the market due to safety concerns.
- 2 Comments